German biotechnology business 3B Pharmaceuticals GmbH (3BP) creates targeted radiopharmaceutical medicines and diagnostics for oncology conditions with a high unmet medical need. As a pioneer in peptide optimization and discovery, 3BP has developed a technology platform that covers everything from hit detection to preliminary clinical testing.
